Article
Radiation induced non-targeted response: mechanism and potential clinical implications.
Center for Radiological Research, Department of Radiation Oncology, Columbia University Medical Center, Vanderbilt Clinic, New York, USA.
Current Molecular Pharmacology
12/2010;
4(2):96-105.
pp.96-105
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Translational approaches to treatment-induced symptoms in cancer patients.
[show abstract] [hide abstract]
ABSTRACT: Cancer therapy makes patients sick. The therapies that are available to clinicians allow them to successfully control nausea, emesis and pain. However, this is not the case for a number of other symptoms that include fatigue, distractibility, poor memory, and diminished interest in previously pleasurable activities. These symptoms cluster during the course of cancer therapy and impair patient quality of life, limit therapy options and do not always resolve at the cessation of treatment. It is possible to describe the intensity and temporal features of symptoms and assess their relationship with the inflammatory response that is associated with cancer and cancer therapy. At the preclinical level, sophisticated animal models still need to be deployed to study the causal role of inflammation in specific components of cancer-related symptoms. Various approaches can be optimally combined in a translational symptom research pathway to provide a framework for assessing in a systematic manner the neurobehavioral toxicity of existing and newly developed cancer therapies. Ultimately, this knowledge will allow derivation of mechanism-based interventions to prevent or alleviate cancer-related symptoms.Nature Reviews Clinical Oncology 05/2012; 9(7):414-26. · 11.96 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
biological consequences
bystander cells
bystander cells exhibit genomic instability
bystander phenomenon
direct damage
heritable biological effects
increase therapeutic gain
induced NF-κB-dependent gene expression
interleukin 33
irradiated cells
NF-κB-dependent gene expression
prostaglandin E2
radiation biology
radiation exposure
radiation induced bystander effects
radiation induced secondary cancer
Radiation-induced non-targeted/bystander effects
tumor necrosis factor
various modulating factors
whole organisms